Sei Investments Co. lessened its holdings in shares of R1 RCM Inc. (NASDAQ:RCM) by 56.8% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 48,046 shares of the healthcare provider’s stock after selling 63,157 shares during the quarter. Sei Investments Co.’s holdings in R1 RCM were worth $1,070,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also modified their holdings of RCM. Harvest Fund Management Co. Ltd acquired a new stake in R1 RCM in the first quarter valued at approximately $26,000. Captrust Financial Advisors raised its holdings in R1 RCM by 413.8% during the first quarter. Captrust Financial Advisors now owns 1,156 shares of the healthcare provider’s stock worth $29,000 after purchasing an additional 931 shares in the last quarter. CIBC Asset Management Inc acquired a new stake in R1 RCM during the first quarter worth approximately $236,000. Teacher Retirement System of Texas raised its holdings in R1 RCM by 22.5% during the first quarter. Teacher Retirement System of Texas now owns 10,932 shares of the healthcare provider’s stock worth $270,000 after purchasing an additional 2,008 shares in the last quarter. Finally, Aigen Investment Management LP acquired a new stake in R1 RCM during the first quarter worth approximately $290,000. 41.53% of the stock is currently owned by institutional investors and hedge funds.
In other news, insider Richard B. Jr. Evans sold 7,000 shares of R1 RCM stock in a transaction on Thursday, August 12th. The stock was sold at an average price of $20.08, for a total transaction of $140,560.00. Following the completion of the transaction, the insider now owns 164,543 shares of the company’s stock, valued at approximately $3,304,023.44. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 59.40% of the company’s stock.
NASDAQ:RCM opened at $21.29 on Tuesday. The company has a market capitalization of $5.94 billion, a PE ratio of -10.33 and a beta of 0.79. The company has a quick ratio of 1.49, a current ratio of 1.49 and a debt-to-equity ratio of 1.55. R1 RCM Inc. has a 52-week low of $15.02 and a 52-week high of $31.28. The stock has a fifty day simple moving average of $20.29 and a 200-day simple moving average of $22.85.
R1 RCM (NASDAQ:RCM) last released its quarterly earnings results on Tuesday, August 3rd. The healthcare provider reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.03). The firm had revenue of $353.40 million for the quarter, compared to analyst estimates of $343.94 million. R1 RCM had a return on equity of 49.25% and a net margin of 9.61%. The company’s quarterly revenue was up 12.3% compared to the same quarter last year. During the same period last year, the firm earned $0.04 EPS. As a group, equities analysts anticipate that R1 RCM Inc. will post -2.01 earnings per share for the current year.
R1 RCM Company Profile
R1 RCM, Inc engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Chicago, IL.
Recommended Story: What is basic economics?
Want to see what other hedge funds are holding RCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for R1 RCM Inc. (NASDAQ:RCM).
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.